Discontinued — last reported Q2 '24
Over 3 years (FY 2021 to FY 2024), Sleep and Respiratory Care — Business acquisitions shows an upward trend with a 151.0% CAGR.
Higher values indicate aggressive inorganic growth strategies, while lower values suggest a focus on organic growth or capital preservation.
Captures the total cash or consideration paid to acquire other companies or business units focused on sleep and respirat...
Standard metric for growth-oriented healthcare firms; peers often disclose this in the cash flow statement under investing activities.
rmd_segment_sleep_and_respiratory_care_business_acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.46M | $9.74M | $9.74M | $9.74M | $9.74M | $19.28M | $0.00 | $0.00 | $0.00 | $74.42M | $3.30M | $0.00 | $14.48M |
| QoQ Change | — | +568.3% | +0.0% | +0.0% | +0.0% | +98.0% | -100.0% | — | — | — | -95.6% | -100.0% | — |
| YoY Change | — | — | — | — | +568.3% | +98.0% | -100.0% | -100.0% | -100.0% | +286.0% | — | — | — |